On December 9, 2019, HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.41 CNY | +0.16% | -4.47% | -18.03% |
1st Jan change | Capi. | |
---|---|---|
-18.03% | 512M | |
+19.98% | 71.4B | |
+2.69% | 8.55B | |
+8.19% | 8.43B | |
-25.47% | 7.46B | |
+12.58% | 5.23B | |
+1.58% | 4.29B | |
+0.34% | 4.03B | |
+5.71% | 3.89B | |
+20.20% | 3.59B |
- Stock Market
- Equities
- 600829 Stock
- News HPGC Renmintongtai Pharmaceutical Corporation
- HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.